Autonomous thyroid nodules visualized by positron emission tomography with 18F-fluorodeoxyglucose: A case report and review of the literature

Thyroid

Volumn 13, Issue 4, 2003, Pages 395-399

  Gianoukakis, Andrew G ^a,c   Karam, M ^a   Cheema, A ^a   Cooper, J A ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b AAHRPP Inc   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; PERTECHNETIC ACID TC 99M;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTHYROIDISM; LABORATORY TEST; NECK; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; THYROID FUNCTION TEST; THYROID GLAND; THYROID HYPERPLASIA; THYROID NODULE; THYROID SCINTISCANNING;

EID: 0037687743     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/105072503321669893     Document Type: Article

References (33)

1. Gharib H 1997 Changing concepts in the diagnosis and management of thyroid nodules. Endocrinol Metab Clin North Am 26:777-800.
2. Mazzaferri EL, de los Santos ET, Rofagha-Keyhani S 1988 Solitary thyroid nodule: Diagnosis and management. Med Clin North Am 72:1177-1211.
3. Corvilain B, Dumont JE, Vassart G 2000 Toxic adenoma and toxic multinodular goiter. In: Braverman LE, Utiger RD (ed) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 564-572.
4. Kaplan MM 2000 Evaluation of thyroid nodules by needle biopsy. In: Braverman LE, Utiger RD (ed) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 446.
5. DeGroot LJ, Larsen PR, Hennemann G 1996 Thyrotoxicosis of other etiologies. In: The Thyroid and its Diseases. 6th ed. Churchill Livingstone, Philadelphia, pp. 496.
6. Grunwald F, Kalicke T, Feine U, Lietzenmayer R, Scheidhauer K, Dietlein M, Schober O, Lerch H, Brandt-Mainz K, Burchert W, Hiltermann G, Cremerius U, Biersack HJ 1999 Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: Results of a multicentre study. Eur J Nucl Med 26:1547-1552.
7. Feine U, Lietzenmayer R, Hanke JP, Held J, Wohrle H, Muller-Schauenburg W 1996 Fluorine-18 FDG and iodine131-iodide uptake in thyroid cancer. J Nucl Med 37:1468-1472.
8. Minn H, Joensuu H, Ahonen A, Klemi P 1988 Fluorode-oxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors. Cancer 61:1776-1781.
9. Joensuu H, Ahonen A 1987 Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. J Nucl Med 28:910-914.
10. Joensuu H, Ahonen A, Klemi PJ 1988 18F-fluorodeoxyglucose imaging in preoperative diagnosis of thyroid malignancy. Eur J Nucl Med 13:502-506.
11. Uematsu H, Sadato N, Ohtsubo T, Tsuchida T, Nakamura S, Sugimoto K, Waki A, Takahashi N, Yonekura Y, Tsuda G, Saito H, Hayashi N, Yamamoto K, Ishii Y 1998 Fluorine-18-fluorodeoxyglucose PET versus thallium-201 scintigraphy evaluation of thyroid tumors. J Nucl Med 39:453-459.
12. Sasaki M, Ichiya Y, Kuwahara Y, Akashki Y, Yoshida T, Fukumara T, Masuda K 1997 An evaluation of FDG-PET in the detection and differentiation of thyroid tumors. Nucl Med Commun 18:957-963.
13. Adler LP, Bloom AD 1993 Positron emission tomography of thyroid masses. Thyroid 3:195-200.
14. Bloom AD, Adler LP, Shuck JM 1993 Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 114:728-735.
15. Reimer SE, Adler LP, Bloom AD 1998 Prospective evaluation of PET FDG in FNA-indeterminate thyroid nodules [abstract 482]. Proceedings of the 45th Annual Meeting of Society of Nuclear Medicine, Vol. 39, pp. 123.
16. Yasuda S, Shohtsu A, Ide M, Takagi S, Takahashi W, Suzuki Y, Horiuchi M 1998 Chronic thyroiditis: Diffuse uptake of FDG at PET. Radiology 207:775-778.
17. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H 2000 Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PET. Exp Clin Endocrinol Diabetes 108:191-196.
18. Boerner AR, Voth E, Theissen P, Wienhard K, Wagner R, Schicha H 1998 Glucose metabolism of the thyroid in Graves' disease measured by F-18-fluoro-deoxyglucose positron emission tomography. Thyroid 8:765-772.
19. Corvilain B, Dumont JE, Vassart G 2000 Toxic adenoma and toxic multinodular goiter. In: Braverman LE, Utiger RD (ed) Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Philadelphia, Lippincott Williams & Wilkins, pp. 564-566.
20. Tonacchera M, Chiovato L, Pinchera A, Agretti P, Fiore E, Cetani F, Rocchi R, Viacava P, Miccoli P, Vitti P 1998 Hyperfunctioning thyroid nodules in toxic multinodular goiter share activating thyrotropin receptor mutations with solitary toxic adenoma. J Clin Endocrinol Metab 83:492-498.
21. Tonacchera M, Vitti P, Agretti P, Giulianetti B, Mazzi B, Cavaliere R, Ceccarini G, Fiore E, Viacava P, Naccarato A, Pinchera A, Chiovato L 1998 Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. Thyroid 8: 559-564.
22. Paschke R, Ludgate M 1997 The thyrotropin receptor in thyroid diseases. N Engl J Med 337:1675-1680.
23. Tonacchera M, Agretti P, Chiovato L, Rosellini V, Ceccarini G, Perri A, Viacava P, Naccarato AG, Miccolo P, Pinchera A, Vitti P 2000 Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter. J Clin Endocrinol Metab 85:2270-2274.
24. DeGroot LJ, Larsen PR, Hennemann G 1996 The phylogeny, ontogeny, anatomy, and metabolic regulation of the thyroid. In: The Thyroid and its Diseases, 6 ed. Churchill Livingstone, New York, pp. 14-18.
25. Hosaka Y, Tawata M, Kurihara A, Ohtaka M, Endo T, Onaya T 1992 The regulation of two distinct glucose transporter (GLUT1 and GLUT2) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 131:159-165.
26. Filetti S, Damante G, Foti D 1987 Thyrotropin stimulates glucose transport in cultured rat thyroid cells. Endocrinology 120:2576-2581.
27. 18F]fluorodeoxyglucose uptake by differentiated thyroid carcinoma. Eur J Nucl Med 29: 641-647.
28. Shreve PD, Anzai Y, Wahl RL 1999 Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants. Radiographics 19:61-77.
29. Gordon BA, Flanagan FL, Dehdashti F 1997 Whole-body positron emission tomography: Normal variations, pitfalls, and technical considerations. AJR 169:1675-1680.
30. McDougall IR, Davidson J, Segall GM 2001 Positron emission tomography of the thyroid, with an emphasis on thyroid cancer. Nucl Med Commun 22:485-492.
31. Zhu Z, Chou C, Yen TC, Cui R 2001 Elevated F-18 FDG uptake in laryngeal muscles mimicking thyroid cancer metastases. Clin Nucl Med 26:689-691.
32. Cohen MS, Arslan N, Dehdashti F, Doherty GM, Lairmore TC, Brunt LM, Moley JF 2001 Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 130:941-946.
33. Van Den Bruel A, Maes A, De Potter T, Mortelmans L, Drijkoningen M, Van Damme B, Delaere P, Bouillon R 2002 Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab 87:1517-1520.